BriaCell Therapeutics Corp. Common Shares (BCTX)
BCTX trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.71
-4.13% on the day
Market cap
$32.3M
Nano cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | BCTX on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Canada |
| IPO year | Not reported by the screener |
| SEC CIK | 0001610820 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | A1 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-06-02 |
| Latest annual report | 10-K | 2025-10-16 |
| Latest quarterly / interim | 10-Q | 2026-06-09 |
| Latest current report | 8-K | 2026-06-26 |
| Latest proxy | DEF 14A | 2026-02-12 |
Source: SEC EDGAR submissions feed, 323 recent filings. All filings on EDGAR.
Other listings for this company
| Ticker | Name | Price |
|---|---|---|
| BCTXL | BriaCell Therapeutics Corp. Warrant expiring 2031 | $1.06 |
| BCTXZ | BriaCell Therapeutics Corp. Warrant expiring 2030 | $0.2007 |
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| CPHI | China Pharma Holdings Inc. | $0.7514 | -13.53% | $32.3M |
| GRDX | GridAI Technologies Corp. | $4.55 | -2.36% | $32.4M |
| JAGX | Jaguar Health Inc. | $4.16 | -10.35% | $32.5M |
| RMTI | Rockwell Medical Inc. | $7.85 | +3.70% | $31.6M |
| ATNM | Actinium Pharmaceuticals Inc. (Delaware) | $0.9995 | -5.71% | $31.4M |
| NNVC | NanoViricides Inc. | $1.32 | +3.13% | $33.7M |
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier